Apollo Hospitals reports 33 percent drop in Q3 profit

Total revenue from operation increased 17 percent to 42.64 billion rupees.

Published On 2023-02-15 04:30 GMT   |   Update On 2023-02-15 11:55 GMT
Advertisement

Mangaluru: Indian healthcare group Apollo Hospitals Enterprise Ltd reported a 33 percent drop in the third-quarter profit on Tuesday, hurt by weakness in its digital business.

Consolidated net profit plunged to 1.53 billion rupees ($18.48 million) for the three months ended Dec. 31, from 2.28 billion rupees, a year earlier, as total expenses surged about 22 percent to 40.12 billion rupees.
The Chennai-based company recorded a loss of 215.4 million rupees related to its joint ventures.
Advertisement
The company's digital health business, which houses the Apollo 24x7 operations, recorded a 34.5 percent jump in revenue to 17.58 billion rupees, but posted a loss of 742.3 million rupees, compared to a profit of 321 million rupees a year earlier.
Total revenue from operation increased 17 percent to 42.64 billion rupees. India's Apollo has been expanding its presence in the domestic healthcare market through mergers and acquisitions.
In December, the company acquired a 60 percent stake in Kerala First Health to diversify its portfolio into ayurveda medical care. Its subsidiary Apollo Rajshree Hospital bought a majority stake in Sobhagya Hospital and Research Centre.
The company also declared an interim dividend of 6 rupees per share in an exchange filing.

Read also: Apollo Hospitals launches AI based Clinical Intelligence Engine for doctors

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News